Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,154,437
-$18,630 QoQ
Shares Held
3,188
-4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#1,608
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chesapeake Wealth Management holds $12,931,041 across 7 Drug Manufacturers - General names. AMGN ranks #5 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,031 | $3,635,471 | |
| 2 | ABBV |
AbbVie Inc.
|
14,357 | $3,612,794 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,024 | $1,930,584 | |
| 4 | JNJ |
Johnson & Johnson
|
7,575 | $1,923,822 | |
| 5 | AMGN |
Amgen Inc
This page
|
3,188 | $1,154,437 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,265 | $360,989 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,477 | $312,944 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,154,437 | 3,188 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,173,067 | 3,334 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,119,072 | 3,419 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $971,614 | 3,443 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $956,014 | 3,424 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,072,977 | 3,444 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $946,123 | 3,630 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,191,854 | 3,699 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,161,063 | 3,716 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,106,857 | 3,893 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,157,263 | 4,018 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,094,659 | 4,073 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $926,933 | 4,175 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,027,436 | 4,250 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $1,125,937 | 4,287 | Shares | Sole | 2023-02-23 | |
| 2022-09-30 | $966,289 | 4,287 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $1,055,434 | 4,338 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $1,057,236 | 4,372 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $1,013,714 | 4,506 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,034,754 | 4,866 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,505,399 | 6,176 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,646,375 | 6,617 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,579,550 | 6,870 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $1,786,236 | 7,028 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,671,067 | 7,085 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,437,152 | 7,089 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||